Cresylbenzodioxaphosphorin oxide pretreatment alters soman-induced toxicity and inhibition of tissue cholinesterase activity of the rat

18Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The toxicity of soman was investigated in the rat with and without pretreatment with Cresylbenzodioxa-phosphorin oxide (CBDP). Without pretreatment, the 24-h LD50for soman was 118.2 μg/kg s.c., and soman inhibited Carboxylesterase (CaE) activity in plasma (ED50of 55 μg/kg) and cholinesterase (ChE) activity in brain regions (ED50values of 65-105 μg/kg) in a dose-related manner. With pretreatment, the 24-h LD50for soman was reduced by approximately 6-fold and 8-fold (by 1.0 mg/kg and 16.0 mg/kg of CBDP, respectively), and the ED50values for soman-induced inhibition of ChE activity in brain regions were reduced by approximately 10-fold (by 1.0 mg/kg of CBDP). The dose-dependent severity of soman intoxication varied widely in rats treated with soman alone but not in CBDP-pretreated rats, and the ED50for the occurrence of signs of soman intoxication was reduced approximately 7-fold following CBDP (1.0 mg/kg) pretreatment. These data support the hypothesis that CBDP pretreatment effectively blocks tissue CaE sites which serve to detoxify soman, thus potentiating both the soman-induced inhibition of ChE in the CNS and the lethality of soman. © 1989.

Cite

CITATION STYLE

APA

Jimmerson, V. R., Tsung-Ming, S., Maxwell, D. M., & Mailman, R. B. (1989). Cresylbenzodioxaphosphorin oxide pretreatment alters soman-induced toxicity and inhibition of tissue cholinesterase activity of the rat. Toxicology Letters, 48(1), 93–103. https://doi.org/10.1016/0378-4274(89)90190-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free